Join us at DIA 2016 Annual Meeting
in Philadelphia, PA June 26-30!

Join us for the 68th AACC Annual
Scientific Meeting & Clinical Lab Expo
in Philadelphia, PA July 31-Aug. 4!

Aushon BioSystems Launches New Ciraplex ULTRA
Ultrasensitive Assays, in Conjunction with Pacific
Biomarkers Comparative Platform Study

Biomarker Testing Services Specializing in
Phase I – IV Studies     Read Article  

Introducing the Pacific Biomarkers Mobile App, available
now on the Apple App Store and Google Play!

An innovative and unique way we connect with our clients.

Pacific Biomarkers is a specialty biomarker testing laboratory that
has supported clinical trials for more than 25 years. Learn More

Download now for phones
and tablets from...

Clinical Chemistry Q&A:

Preanalytical Considerations in the Design of
Clinical Trials and Epidemiological Studies

Featuring Amar A. Sethi MD., PhD.,
Chief Scientific Officer

Read Article  

Clin Chem 2015;61:797-803

From Patient to Plate:

Development of Highly Sensitive Clinical PK Assays

Presented by Sarah Christensen B.S.

Click here to view the presentation  

Together We Offer More.

The Pacific Biomarkers-Clinigene partnership combines biomarker support for clinical trial research of the former with development capabilities of ligandbinding assays of the latter in a cost-effective business model situated in India.

Learn More  

Announcing Singulex
Erenna Immunoassay Technology

Pacific Biomarkers announces the expansion of its services portfolio to include ultra-sensitive biomarker assays using the Singulex Erenna Immunoassay technology.

Read More  

Pacific Biomarkers has provided clients with specialty biomarker testing services for more than 27 years, and has one of the largest biomarker libraries in the industry.  Read More

Biomarker Menu Search:

Premium Analysis of Angiogenesis Biomarkers

Presented by Jeff Chamberlain, Ph.D.

View presentation  
See the BIOMARKER NAVIGATOR in action. It's never been easier to identify Biomarkers for your next clinical trial.

Watch Video  

Loading Tweets...